By G HossainPosted on September 24, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The issues the regulator found include the failure to comprehensively review complaints and product defects. FDA Hits J&J With Warning Letter Over ‘Significant Violations’ at Korean Production Plant Post navigation Lilly Unveils Second Facility in Manufacturing Push, Naming Texas as Site of New $6.5B PlantSanofi Fattens Venture Unit With $625M Infusion for Rare Disease, Neuro Innovation